Evidence map›Paper›PMID 26055104›Full record

ArticleRetrovirology2015

Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes.

Paul J Peters, Maria Paz Gonzalez-Perez, Thomas Musich, Tiffany A Moore Simas, Rongheng Lin, Abraham N Morse, Robin J Shattock, Cynthia A Derdeyn, Paul R Clapham

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. T-Cell Biology in the Female Reproductive Tract: Relevance to HIV Infection.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Paul J PetersProgram in Molecular Medicine and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Biotech 2, 373 Plantation Street, Worcester, MA, 01605-2377, USA. paul.peters@umassmed.edu.
Maria Paz Gonzalez-PerezProgram in Molecular Medicine and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Biotech 2, 373 Plantation Street, Worcester, MA, 01605-2377, USA. mariapaz.gonzalez-perez@umassmed.edu.
Thomas MusichProgram in Molecular Medicine and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Biotech 2, 373 Plantation Street, Worcester, MA, 01605-2377, USA. thomas.musich@nih.gov.
Tiffany A Moore SimasDepartment of Ob/Gyn, University of Massachusetts Memorial Health Care, 119 Belmont Street, Worcester, MA, 01605, USA. tiffanya.mooresimas@umassmemorial.org.
Rongheng LinSchool of Public Health and Health Sciences, University of Massachusetts, 411 Arnold House, 715 North Pleasant Street, Amherst, MA, 01003-9304, USA. rlin04@gmail.com.
Abraham N MorseDepartment of Ob/Gyn, University of Massachusetts Memorial Health Care, 119 Belmont Street, Worcester, MA, 01605, USA. anmorse@partners.org.
Robin J ShattockDepartment of Medicine, St Mary's Campus, Imperial College, Medical School Building, London, W21PG, UK. r.shattock@imperial.ac.uk.
Cynthia A DerdeynDepartment of Pathology and Laboratory Medicine, Emory Vaccine Center at Yerkes National Primate Center, Emory University, 954 Gatewood Road, Atlanta, GA, 30329, USA. cderdey@emory.edu.
Paul R ClaphamProgram in Molecular Medicine and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Biotech 2, 373 Plantation Street, Worcester, MA, 01605-2377, USA. paul.clapham@umassmed.edu.
University of Massachusetts Chan Medical School · USUniversity of Massachusetts Amherst · USEmory University · USImperial College London · GB

Funding

UMASS MEDICAL CENTER FOR AIDS RESEARCHP30AI042845 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 1998 to 2012
$13.0M
Variation in HIV-1 R5 Envs: Consequences for tropism, neutralization & vaccinesP01AI082274 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LU, SHAN · 2009 to 2013
$9.7M
Role of V1V2 in HIV transmission and pathogenesisR01AI058706 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DERDEYN, CYNTHIA ANN · 2004 to 2016
$6.7M
HIV-1 R5 envelope determinants and properties that affect transmissionR01AI089334 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CLAPHAM, PAUL R · 2011 to 2015
$2.0M
Neurotropic HIV-1 Reservoirs Inside and Outside the BrainR01NS084910 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CLAPHAM, PAUL R · 2013 to 2017
$2.0M
NIAID NIH HHS P01 AI082274NIAID NIH HHS P30 AI042845NIAID NIH HHS R01 AI058706NIAID NIH HHS R01 AI082274NIAID NIH HHS R01 AI089334NIAID NIH HHS R01 AI58706NINDS NIH HHS R01 NS084910
6 · The paper itself

Abstract

backgroundHIV-1 variants carrying non-macrophage-tropic HIV-1 R5 envelopes (Envs) are predominantly transmitted and persist in immune tissue even in AIDS patients who have highly macrophage-tropic variants in the brain. Non-macrophage-tropic R5 Envs require high levels of CD4 for infection contrasting with macrophage-tropic Envs, which can efficiently mediate infection of cells via low CD4. Here, we investigated whether non-macrophage-tropic R5 Envs from the acute stage of infection (including transmitted/founder Env) mediated more efficient infection of ectocervical explant cultures compared to non-macrophage-tropic and highly macrophage-tropic R5 Envs from late disease.

resultsWe used Env+ pseudovirions that carried a GFP reporter gene to measure infection of the first cells targeted in ectocervical explant cultures. In straight titrations of Env+ pseudovirus supernatants, mac-tropic R5 Envs from late disease mediated slightly higher infectivities for ectocervical explants although this was not significant. Surprisingly, explant infection by several T/F/acute Envs was lower than for Envs from late disease. However, when infectivity for explants was corrected to account for differences in the overall infectivity of each Env+ pseudovirus (measured on highly permissive HeLa TZM-bl cells), non-mac-tropic early and late disease Env+ pseudoviruses mediated significantly higher infection. This observation suggests that cervical tissue preferentially supports non-mac-tropic Env+ viruses compared to mac-tropic viruses. Finally, we show that T-cells were the main targets for infection regardless of whether explants were stimulated with T-cell or monocyte/macrophage cytokines. There was no evidence of macrophage infection even for pseudovirions carrying highly mac-tropic Envs from brain tissue or for the highly mac-tropic, laboratory strain, BaL, which targeted T-cells in the explant tissue.

conclusionsOur data support ectocervical tissue as a favorable environment for non-mac-tropic HIV-1 R5 variants and emphasize the role of T-cells as initial targets for infection even for highly mac-tropic variants.

Indexed as

Viral TropismCells, Culturedenv Gene Products, Human Immunodeficiency VirusHIV-1HumansT-Lymphocytesenv Gene Products, Human Immunodeficiency Virus

Identifiers

PMID26055104
PMCPMC4459458
OpenAlexW1499236056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.